Analysis of longitudinal randomized clinical trials using item response models
Abstract Patient-relevant outcomes, such as impairments, disability and health-related quality of life, are becoming increasingly popular as outcome measures in clinical research. These outcomes are generally assessed using questionnaires. In a longitudinal randomized clinical trial where the outcom...
Gespeichert in:
Veröffentlicht in: | Contemporary clinical trials 2009-03, Vol.30 (2), p.158-170 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 170 |
---|---|
container_issue | 2 |
container_start_page | 158 |
container_title | Contemporary clinical trials |
container_volume | 30 |
creator | Glas, Cees A.W Geerlings, Hanneke van de Laar, Mart A.F.J Taal, Erik |
description | Abstract Patient-relevant outcomes, such as impairments, disability and health-related quality of life, are becoming increasingly popular as outcome measures in clinical research. These outcomes are generally assessed using questionnaires. In a longitudinal randomized clinical trial where the outcome is measured by a questionnaire or some other instrument consisting of a set of discretely scored items, treatment effects can be analyzed using item response theory. The problem addressed is how to take the estimation error in the estimates of the latent outcome variables into account in the estimation of the treatment effects. Three approaches are compared: plausible value imputation (PVI), concurrent marginal maximum likelihood (MML) estimation and a limited information two-step marginal maximum likelihood method. The results show that the power of the former two methods to detect small and moderate effect sizes is considerably larger than the power of the latter approach. An additional advantage of the PVI method as compared to MML is that the treatment effects can be estimated with standard software. An example using data from a longitudinal randomized clinical trial illustrates the use of the methods in a practical setting. It is shown that even when responses on different sets of items for different groups of patients are used for the data analysis, the power to detect the experimental effects is comparable to the power obtained when responses to all items for all patients are used in the analysis. This creates considerable flexibility in the design and use of measures in experiments. |
doi_str_mv | 10.1016/j.cct.2008.12.003 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733920528</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1551714408001535</els_id><sourcerecordid>733920528</sourcerecordid><originalsourceid>FETCH-LOGICAL-c480t-fceddfa7d47d89d1b15901f5dedc5b1957f7595002ca1801c03bb3235fc1638e3</originalsourceid><addsrcrecordid>eNp9kU1v1DAQhi1ERT_gB3BBuSBOCTN2nA8hIVUVFKSqPRTOVmJPKi9JvHgSpOXX4-0uIHHgZGv0zIz9vEK8RCgQsHq7KaxdCgnQFCgLAPVEnKHWbS5BwdPHO-Y1luWpOGfeJKDSlX4mTrHFsmpbPBO3l3M37thzFoZsDPODX1bnUy2L3ezC5H-Sy-zoZ29TbYm-Gzlb2c8PmV9oyiLxNsxM2RQcjfxcnAyJoBfH80J8_fjhy9Wn_Obu-vPV5U1uywaWfLDk3NDVrqxd0zrsUbeAg3bkrO6x1fVQ61YDSNthA2hB9b2SSg8WK9WQuhBvDnO3MXxfiRczebY0jt1MYWVTK9VK0LJJJB5IGwNzpMFso5-6uDMIZm_RbEyyaPYWDUqTJKWeV8fpaz-R-9tx1JaA10eg4-RlSK6s5z-cRFnV8nH5uwOX1NAPT9Gw9TSn3_tIaakL_r_PeP9P9-8gvtGOeBPWmIJig4ZTg7nfx71PGxoA1EqrX2rbpOE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733920528</pqid></control><display><type>article</type><title>Analysis of longitudinal randomized clinical trials using item response models</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Glas, Cees A.W ; Geerlings, Hanneke ; van de Laar, Mart A.F.J ; Taal, Erik</creator><creatorcontrib>Glas, Cees A.W ; Geerlings, Hanneke ; van de Laar, Mart A.F.J ; Taal, Erik</creatorcontrib><description>Abstract Patient-relevant outcomes, such as impairments, disability and health-related quality of life, are becoming increasingly popular as outcome measures in clinical research. These outcomes are generally assessed using questionnaires. In a longitudinal randomized clinical trial where the outcome is measured by a questionnaire or some other instrument consisting of a set of discretely scored items, treatment effects can be analyzed using item response theory. The problem addressed is how to take the estimation error in the estimates of the latent outcome variables into account in the estimation of the treatment effects. Three approaches are compared: plausible value imputation (PVI), concurrent marginal maximum likelihood (MML) estimation and a limited information two-step marginal maximum likelihood method. The results show that the power of the former two methods to detect small and moderate effect sizes is considerably larger than the power of the latter approach. An additional advantage of the PVI method as compared to MML is that the treatment effects can be estimated with standard software. An example using data from a longitudinal randomized clinical trial illustrates the use of the methods in a practical setting. It is shown that even when responses on different sets of items for different groups of patients are used for the data analysis, the power to detect the experimental effects is comparable to the power obtained when responses to all items for all patients are used in the analysis. This creates considerable flexibility in the design and use of measures in experiments.</description><identifier>ISSN: 1551-7144</identifier><identifier>EISSN: 1559-2030</identifier><identifier>DOI: 10.1016/j.cct.2008.12.003</identifier><identifier>PMID: 19146991</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Biological and medical sciences ; Cardiovascular ; Clinical trial. Drug monitoring ; Data Interpretation, Statistical ; General pharmacology ; Health-related quality of life ; Hematology, Oncology and Palliative Medicine ; Humans ; Item response theory ; Likelihood Functions ; Linear Models ; Longitudinal Studies ; Marginal maximum likelihood estimation ; Medical sciences ; Models, Statistical ; Patient-relevant outcomes ; Pharmacology. Drug treatments ; Plausible value imputation ; Quality of Life ; Questionnaires ; Randomized Controlled Trials as Topic ; Sample Size ; Surveys and Questionnaires</subject><ispartof>Contemporary clinical trials, 2009-03, Vol.30 (2), p.158-170</ispartof><rights>Elsevier Inc.</rights><rights>2008 Elsevier Inc.</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c480t-fceddfa7d47d89d1b15901f5dedc5b1957f7595002ca1801c03bb3235fc1638e3</citedby><cites>FETCH-LOGICAL-c480t-fceddfa7d47d89d1b15901f5dedc5b1957f7595002ca1801c03bb3235fc1638e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1551714408001535$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21267228$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19146991$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Glas, Cees A.W</creatorcontrib><creatorcontrib>Geerlings, Hanneke</creatorcontrib><creatorcontrib>van de Laar, Mart A.F.J</creatorcontrib><creatorcontrib>Taal, Erik</creatorcontrib><title>Analysis of longitudinal randomized clinical trials using item response models</title><title>Contemporary clinical trials</title><addtitle>Contemp Clin Trials</addtitle><description>Abstract Patient-relevant outcomes, such as impairments, disability and health-related quality of life, are becoming increasingly popular as outcome measures in clinical research. These outcomes are generally assessed using questionnaires. In a longitudinal randomized clinical trial where the outcome is measured by a questionnaire or some other instrument consisting of a set of discretely scored items, treatment effects can be analyzed using item response theory. The problem addressed is how to take the estimation error in the estimates of the latent outcome variables into account in the estimation of the treatment effects. Three approaches are compared: plausible value imputation (PVI), concurrent marginal maximum likelihood (MML) estimation and a limited information two-step marginal maximum likelihood method. The results show that the power of the former two methods to detect small and moderate effect sizes is considerably larger than the power of the latter approach. An additional advantage of the PVI method as compared to MML is that the treatment effects can be estimated with standard software. An example using data from a longitudinal randomized clinical trial illustrates the use of the methods in a practical setting. It is shown that even when responses on different sets of items for different groups of patients are used for the data analysis, the power to detect the experimental effects is comparable to the power obtained when responses to all items for all patients are used in the analysis. This creates considerable flexibility in the design and use of measures in experiments.</description><subject>Biological and medical sciences</subject><subject>Cardiovascular</subject><subject>Clinical trial. Drug monitoring</subject><subject>Data Interpretation, Statistical</subject><subject>General pharmacology</subject><subject>Health-related quality of life</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Item response theory</subject><subject>Likelihood Functions</subject><subject>Linear Models</subject><subject>Longitudinal Studies</subject><subject>Marginal maximum likelihood estimation</subject><subject>Medical sciences</subject><subject>Models, Statistical</subject><subject>Patient-relevant outcomes</subject><subject>Pharmacology. Drug treatments</subject><subject>Plausible value imputation</subject><subject>Quality of Life</subject><subject>Questionnaires</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Sample Size</subject><subject>Surveys and Questionnaires</subject><issn>1551-7144</issn><issn>1559-2030</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU1v1DAQhi1ERT_gB3BBuSBOCTN2nA8hIVUVFKSqPRTOVmJPKi9JvHgSpOXX4-0uIHHgZGv0zIz9vEK8RCgQsHq7KaxdCgnQFCgLAPVEnKHWbS5BwdPHO-Y1luWpOGfeJKDSlX4mTrHFsmpbPBO3l3M37thzFoZsDPODX1bnUy2L3ezC5H-Sy-zoZ29TbYm-Gzlb2c8PmV9oyiLxNsxM2RQcjfxcnAyJoBfH80J8_fjhy9Wn_Obu-vPV5U1uywaWfLDk3NDVrqxd0zrsUbeAg3bkrO6x1fVQ61YDSNthA2hB9b2SSg8WK9WQuhBvDnO3MXxfiRczebY0jt1MYWVTK9VK0LJJJB5IGwNzpMFso5-6uDMIZm_RbEyyaPYWDUqTJKWeV8fpaz-R-9tx1JaA10eg4-RlSK6s5z-cRFnV8nH5uwOX1NAPT9Gw9TSn3_tIaakL_r_PeP9P9-8gvtGOeBPWmIJig4ZTg7nfx71PGxoA1EqrX2rbpOE</recordid><startdate>20090301</startdate><enddate>20090301</enddate><creator>Glas, Cees A.W</creator><creator>Geerlings, Hanneke</creator><creator>van de Laar, Mart A.F.J</creator><creator>Taal, Erik</creator><general>Elsevier Inc</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090301</creationdate><title>Analysis of longitudinal randomized clinical trials using item response models</title><author>Glas, Cees A.W ; Geerlings, Hanneke ; van de Laar, Mart A.F.J ; Taal, Erik</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c480t-fceddfa7d47d89d1b15901f5dedc5b1957f7595002ca1801c03bb3235fc1638e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Biological and medical sciences</topic><topic>Cardiovascular</topic><topic>Clinical trial. Drug monitoring</topic><topic>Data Interpretation, Statistical</topic><topic>General pharmacology</topic><topic>Health-related quality of life</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Item response theory</topic><topic>Likelihood Functions</topic><topic>Linear Models</topic><topic>Longitudinal Studies</topic><topic>Marginal maximum likelihood estimation</topic><topic>Medical sciences</topic><topic>Models, Statistical</topic><topic>Patient-relevant outcomes</topic><topic>Pharmacology. Drug treatments</topic><topic>Plausible value imputation</topic><topic>Quality of Life</topic><topic>Questionnaires</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Sample Size</topic><topic>Surveys and Questionnaires</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Glas, Cees A.W</creatorcontrib><creatorcontrib>Geerlings, Hanneke</creatorcontrib><creatorcontrib>van de Laar, Mart A.F.J</creatorcontrib><creatorcontrib>Taal, Erik</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Contemporary clinical trials</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Glas, Cees A.W</au><au>Geerlings, Hanneke</au><au>van de Laar, Mart A.F.J</au><au>Taal, Erik</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Analysis of longitudinal randomized clinical trials using item response models</atitle><jtitle>Contemporary clinical trials</jtitle><addtitle>Contemp Clin Trials</addtitle><date>2009-03-01</date><risdate>2009</risdate><volume>30</volume><issue>2</issue><spage>158</spage><epage>170</epage><pages>158-170</pages><issn>1551-7144</issn><eissn>1559-2030</eissn><abstract>Abstract Patient-relevant outcomes, such as impairments, disability and health-related quality of life, are becoming increasingly popular as outcome measures in clinical research. These outcomes are generally assessed using questionnaires. In a longitudinal randomized clinical trial where the outcome is measured by a questionnaire or some other instrument consisting of a set of discretely scored items, treatment effects can be analyzed using item response theory. The problem addressed is how to take the estimation error in the estimates of the latent outcome variables into account in the estimation of the treatment effects. Three approaches are compared: plausible value imputation (PVI), concurrent marginal maximum likelihood (MML) estimation and a limited information two-step marginal maximum likelihood method. The results show that the power of the former two methods to detect small and moderate effect sizes is considerably larger than the power of the latter approach. An additional advantage of the PVI method as compared to MML is that the treatment effects can be estimated with standard software. An example using data from a longitudinal randomized clinical trial illustrates the use of the methods in a practical setting. It is shown that even when responses on different sets of items for different groups of patients are used for the data analysis, the power to detect the experimental effects is comparable to the power obtained when responses to all items for all patients are used in the analysis. This creates considerable flexibility in the design and use of measures in experiments.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>19146991</pmid><doi>10.1016/j.cct.2008.12.003</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1551-7144 |
ispartof | Contemporary clinical trials, 2009-03, Vol.30 (2), p.158-170 |
issn | 1551-7144 1559-2030 |
language | eng |
recordid | cdi_proquest_miscellaneous_733920528 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Biological and medical sciences Cardiovascular Clinical trial. Drug monitoring Data Interpretation, Statistical General pharmacology Health-related quality of life Hematology, Oncology and Palliative Medicine Humans Item response theory Likelihood Functions Linear Models Longitudinal Studies Marginal maximum likelihood estimation Medical sciences Models, Statistical Patient-relevant outcomes Pharmacology. Drug treatments Plausible value imputation Quality of Life Questionnaires Randomized Controlled Trials as Topic Sample Size Surveys and Questionnaires |
title | Analysis of longitudinal randomized clinical trials using item response models |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T20%3A05%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Analysis%20of%20longitudinal%20randomized%20clinical%20trials%20using%20item%20response%20models&rft.jtitle=Contemporary%20clinical%20trials&rft.au=Glas,%20Cees%20A.W&rft.date=2009-03-01&rft.volume=30&rft.issue=2&rft.spage=158&rft.epage=170&rft.pages=158-170&rft.issn=1551-7144&rft.eissn=1559-2030&rft_id=info:doi/10.1016/j.cct.2008.12.003&rft_dat=%3Cproquest_cross%3E733920528%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=733920528&rft_id=info:pmid/19146991&rft_els_id=1_s2_0_S1551714408001535&rfr_iscdi=true |